Checkpoint Therapeutics, Inc

Outlook Therapeutics, Inc. is a late clinical-stage biopharmaceutical company focused on developing and introducing the first FDA-approved ophthalmic formulation of bevacizumab for retinal indications. The company's primary areas of focus include wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), and branch retinal vein occlusion (BRVO). Generated from their website's infomation

AmeriDerm Laboratories is a trusted provider of healthcare products, offering a wide range of lotions, creams, ointments, body washes, and wound care solutions. Their high-quality products, such as DermaSoft with Aloe and AmeriCerin, are designed to meet the needs of healthcare professionals, providing effective solutions for various skin conditions and incontinence care.Generated from the website

Founded in 1994, Ranbaxy Pharmaceuticals offers various research and development services, such as laboratory tests, clinical research, drug development, in-licensing, promotion, distribution and marketing support solutions. The company provides a range of tablets, caplets, capsules, laxatives, antacids and analgesics for cough and cold, diabetes and skin treatments. It offers products under the brand names of Proctosol, Riomet, Sotret, Flomax and Cipro. Ranbaxy Pharmaceuticals also provides various formulations for the commercial production of ibuprofens, acetaminophens, pseudoephedrines and ciprofloxacin products. The company distributes its products in more than 125 countries worldwide. It is a wholly owned subsidiary of Ranbaxy Laboratories Limited, which manufactures a variety of generic and patented pharmaceuticals.